BAFNA PHARMACEUTICALS
|
BAFNA PHARMACEUTICALS Last 5 Year Balance Sheet History
[Standalone]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
EQUITY AND LIABILITIES | |||||
Share Capital | ₹24 Cr | ₹24 Cr | ₹24 Cr | ₹24 Cr | ₹2.37 Cr |
Equity - Authorised | ₹40 Cr | ₹40 Cr | ₹40 Cr | ₹40 Cr | ₹40 Cr |
Equity - Issued | ₹24 Cr | ₹24 Cr | ₹24 Cr | ₹24 Cr | ₹2.37 Cr |
Equity Paid Up | ₹24 Cr | ₹24 Cr | ₹24 Cr | ₹24 Cr | ₹2.37 Cr |
Equity Shares Forfeited | - | - | - | - | - |
Adjustments to Equity | - | - | - | - | - |
Preference Capital Paid Up | - | - | - | - | - |
Face Value | ₹10.00 | ₹10.00 | ₹10.00 | ₹10.00 | ₹10.00 |
Share Warrants & Outstandings | - | - | - | - | ₹55 Cr |
Total Reserves | ₹57 Cr | ₹50 Cr | ₹38 Cr | ₹33 Cr | ₹-6.78 Cr |
Securities Premium | ₹75 Cr | ₹75 Cr | ₹75 Cr | ₹75 Cr | ₹41 Cr |
Capital Reserves | ₹27 Cr | ₹27 Cr | ₹27 Cr | ₹27 Cr | ₹27 Cr |
Profit & Loss Account Balance | ₹-47 Cr | ₹-54 Cr | ₹-66 Cr | ₹-71 Cr | ₹-77 Cr |
General Reserves | ₹1.92 Cr | ₹1.92 Cr | ₹1.92 Cr | ₹1.92 Cr | ₹1.92 Cr |
Other Reserves | - | - | - | - | - |
Reserve excluding Revaluation Reserve | ₹57 Cr | ₹50 Cr | ₹38 Cr | ₹33 Cr | ₹-6.78 Cr |
Revaluation reserve | - | - | - | - | - |
Shareholder's Funds | ₹81 Cr | ₹73 Cr | ₹62 Cr | ₹57 Cr | ₹51 Cr |
Minority Interest | - | - | - | - | - |
Long-Term Borrowings | - | - | - | - | - |
Secured Loans | ₹9.25 Cr | ₹6.93 Cr | ₹3.30 Cr | ₹2.50 Cr | - |
Non Convertible Debentures | - | - | - | - | - |
Converible Debentures & Bonds | - | - | - | - | - |
Packing Credit - Bank | - | - | - | - | - |
Inter Corporate & Security Deposit | - | - | - | - | - |
Term Loans - Banks | ₹13 Cr | ₹9.51 Cr | ₹4.45 Cr | - | - |
Term Loans - Institutions | - | - | - | ₹2.50 Cr | - |
Other Secured | ₹-3.63 Cr | ₹-2.58 Cr | ₹-1.15 Cr | - | - |
Unsecured Loans | ₹1.50 Cr | ₹1.51 Cr | ₹2.02 Cr | - | ₹3.02 Cr |
Fixed Deposits - Public | - | - | - | - | - |
Loans and advances from subsidiaries | - | - | - | - | - |
Inter Corporate Deposits (Unsecured) | - | - | - | - | - |
Foreign Currency Convertible Notes | - | - | - | - | - |
Long Term Loan in Foreign Currency | - | - | - | - | - |
Loans - Banks | - | - | - | - | - |
Loans - Govt. | - | - | - | - | - |
Loans - Others | ₹1.50 Cr | ₹1.51 Cr | ₹2.02 Cr | - | ₹3.02 Cr |
Other Unsecured Loan | - | - | - | - | - |
Deferred Tax Assets / Liabilities | - | - | - | - | - |
Deferred Tax Assets | - | - | - | - | - |
Deferred Tax Liability | - | - | - | - | - |
Other Long Term Liabilities | ₹1.62 Cr | ₹1.22 Cr | ₹0.85 Cr | ₹2.79 Cr | - |
Long Term Trade Payables | - | - | - | - | - |
Long Term Provisions | ₹0.39 Cr | - | - | ₹0.10 Cr | - |
Total Non-Current Liabilities | ₹13 Cr | ₹9.65 Cr | ₹6.17 Cr | ₹5.39 Cr | ₹3.02 Cr |
Current Liabilities | - | - | - | - | - |
Trade Payables | ₹35 Cr | ₹28 Cr | ₹12 Cr | ₹11 Cr | ₹13 Cr |
Sundry Creditors | ₹35 Cr | ₹28 Cr | ₹12 Cr | ₹11 Cr | ₹13 Cr |
Acceptances | - | - | - | - | - |
Due to Subsidiaries- Trade Payables | - | - | - | - | - |
Other Current Liabilities | ₹7.39 Cr | ₹4.85 Cr | ₹3.46 Cr | ₹3.62 Cr | ₹4.56 Cr |
Bank Overdraft / Short term credit | - | - | - | - | - |
Advances received from customers | ₹0.16 Cr | ₹0.04 Cr | - | ₹0.89 Cr | ₹2.51 Cr |
Interest Accrued But Not Due | ₹0.09 Cr | ₹0.11 Cr | - | - | - |
Share Application Money | - | - | - | - | - |
Current maturity of Debentures & Bonds | - | - | - | - | - |
Current maturity - Others | - | - | - | - | - |
Other Liabilities | ₹7.13 Cr | ₹4.70 Cr | ₹3.46 Cr | ₹2.73 Cr | ₹2.05 Cr |
Short Term Borrowings | ₹10 Cr | ₹12 Cr | ₹4.59 Cr | ₹10.00 Cr | - |
Secured ST Loans repayable on Demands | ₹10 Cr | ₹12 Cr | ₹4.59 Cr | - | - |
Working Capital Loans- Sec | ₹10 Cr | ₹12 Cr | ₹4.59 Cr | - | - |
Buyers Credits - Unsec | - | - | - | - | - |
Commercial Borrowings- Unsec | - | - | - | - | - |
Other Unsecured Loans | ₹-10 Cr | ₹-12 Cr | ₹-4.59 Cr | ₹10.00 Cr | - |
Short Term Provisions | ₹1.27 Cr | ₹1.26 Cr | ₹1.56 Cr | - | - |
Proposed Equity Dividend | - | - | - | - | - |
Provision for Corporate Dividend Tax | - | - | - | - | - |
Provision for Tax | - | - | - | - | - |
Provision for post retirement benefits | - | - | - | - | - |
Preference Dividend | - | - | - | - | - |
Other Provisions | ₹1.27 Cr | ₹1.26 Cr | ₹1.56 Cr | - | - |
Total Current Liabilities | ₹54 Cr | ₹46 Cr | ₹22 Cr | ₹24 Cr | ₹17 Cr |
Total Liabilities | ₹148 Cr | ₹130 Cr | ₹90 Cr | ₹86 Cr | ₹71 Cr |
ASSETS | |||||
Gross Block | ₹99 Cr | ₹95 Cr | ₹88 Cr | ₹80 Cr | ₹74 Cr |
Less: Accumulated Depreciation | ₹59 Cr | ₹54 Cr | ₹49 Cr | ₹44 Cr | ₹39 Cr |
Less: Impairment of Assets | - | - | - | - | - |
Net Block | ₹40 Cr | ₹40 Cr | ₹39 Cr | ₹36 Cr | ₹35 Cr |
Lease Adjustment A/c | - | - | - | - | - |
Capital Work in Progress | ₹10 Cr | - | - | ₹0.83 Cr | ₹0.21 Cr |
Non Current Investments | - | - | - | - | - |
Long Term Investment | - | - | - | - | - |
Quoted | - | - | - | - | - |
Unquoted | - | - | - | - | - |
Long Term Loans & Advances | ₹0.74 Cr | ₹0.54 Cr | ₹0.42 Cr | - | - |
Other Non Current Assets | - | - | - | - | - |
Total Non-Current Assets | ₹53 Cr | ₹42 Cr | ₹39 Cr | ₹37 Cr | ₹35 Cr |
Current Assets Loans & Advances | - | - | - | - | - |
Currents Investments | - | - | - | - | - |
Quoted | - | - | - | - | - |
Unquoted | - | - | - | - | - |
Inventories | ₹30 Cr | ₹22 Cr | ₹20 Cr | ₹15 Cr | ₹11 Cr |
Raw Materials | ₹15 Cr | ₹13 Cr | ₹9.77 Cr | ₹9.82 Cr | ₹4.43 Cr |
Work-in Progress | ₹9.13 Cr | ₹5.15 Cr | ₹1.19 Cr | ₹0.97 Cr | ₹2.92 Cr |
Finished Goods | ₹3.07 Cr | ₹2.20 Cr | ₹3.24 Cr | ₹1.68 Cr | ₹2.69 Cr |
Packing Materials | - | - | - | ₹2.73 Cr | ₹1.20 Cr |
Stores  and Spare | ₹2.78 Cr | ₹1.96 Cr | ₹6.08 Cr | ₹0.24 Cr | ₹0.18 Cr |
Other Inventory | - | - | - | - | - |
Sundry Debtors | ₹45 Cr | ₹41 Cr | ₹15 Cr | ₹9.56 Cr | ₹6.04 Cr |
Debtors more than Six months | ₹3.52 Cr | ₹4.72 Cr | ₹2.08 Cr | - | ₹0.75 Cr |
Debtors Others | ₹43 Cr | ₹37 Cr | ₹13 Cr | ₹9.56 Cr | ₹5.28 Cr |
Cash and Bank | ₹1.40 Cr | ₹7.81 Cr | ₹0.17 Cr | ₹1.80 Cr | ₹8.48 Cr |
Cash in hand | ₹0.01 Cr | ₹0.00 Cr | ₹0.00 Cr | ₹0.00 Cr | ₹0.00 Cr |
Balances at Bank | ₹1.39 Cr | ₹7.81 Cr | ₹0.17 Cr | ₹1.80 Cr | ₹8.48 Cr |
Other cash and bank balances | - | - | - | - | - |
Other Current Assets | ₹1.27 Cr | ₹0.37 Cr | ₹0.28 Cr | ₹12 Cr | ₹7.42 Cr |
Interest accrued on Investments | ₹0.00 Cr | ₹0.00 Cr | - | - | - |
Interest accrued on Debentures | - | - | - | - | - |
Deposits with Government | ₹0.10 Cr | - | - | ₹0.35 Cr | ₹0.31 Cr |
Interest accrued and or due on loans | - | - | - | - | - |
Prepaid Expenses | ₹0.46 Cr | ₹0.37 Cr | ₹0.28 Cr | ₹0.23 Cr | ₹0.13 Cr |
Other current_assets | ₹0.70 Cr | - | - | ₹11 Cr | ₹6.98 Cr |
Short Term Loans and Advances | ₹17 Cr | ₹16 Cr | ₹15 Cr | ₹11 Cr | ₹2.54 Cr |
Advances recoverable in cash or in kind | ₹0.84 Cr | ₹1.02 Cr | ₹0.64 Cr | ₹11 Cr | ₹2.03 Cr |
Advance income tax and TDS | ₹0.65 Cr | ₹0.48 Cr | ₹0.63 Cr | ₹0.56 Cr | ₹0.43 Cr |
Amounts due from directors | - | - | - | - | - |
Due From Subsidiaries | - | - | - | - | - |
Inter corporate deposits | - | - | - | - | - |
Corporate Deposits | - | - | - | - | - |
Other Loans & Advances | ₹15 Cr | ₹14 Cr | ₹14 Cr | ₹0.16 Cr | ₹0.07 Cr |
Total Current Assets | ₹94 Cr | ₹87 Cr | ₹51 Cr | ₹50 Cr | ₹36 Cr |
Net Current Assets (Including Current Investments) | ₹40 Cr | ₹41 Cr | ₹29 Cr | ₹25 Cr | ₹19 Cr |
Miscellaneous Expenses not written off | - | - | - | - | - |
Total Assets | ₹148 Cr | ₹130 Cr | ₹90 Cr | ₹86 Cr | ₹71 Cr |
Contingent Liabilities | ₹18 Cr | ₹10 Cr | ₹6.17 Cr | ₹2.00 Cr | ₹5.00 Cr |
Total Debt | ₹24 Cr | ₹23 Cr | ₹11 Cr | ₹13 Cr | ₹3.02 Cr |
Book Value | - | 31.05 | 26.19 | 24.00 | -18.64 |
Adjusted Book Value | 34.17 | 31.05 | 26.19 | 24.00 | -18.64 |
Compare Balance Sheet of peers of BAFNA PHARMACEUTICALS
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
BAFNA PHARMACEUTICALS | ₹192.0 Cr | -5.8% | 1.3% | -3.1% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹424,382.0 Cr | -3.7% | -2.5% | 31.9% | Stock Analytics | |
DIVIS LABORATORIES | ₹159,224.0 Cr | 2.3% | 2.1% | 46.9% | Stock Analytics | |
CIPLA | ₹116,943.0 Cr | -3.2% | 0% | 8.2% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹111,588.0 Cr | -2.4% | 7.3% | 15.3% | Stock Analytics | |
ZYDUS LIFESCIENCES | ₹100,704.0 Cr | 2% | 2.3% | 37.9% | Stock Analytics |
BAFNA PHARMACEUTICALS Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
BAFNA PHARMACEUTICALS | -5.8% |
1.3% |
-3.1% |
SENSEX | -2.2% |
-5.9% |
7.2% |
You may also like the below Video Courses